Desmopressin for bleeding in non‐severe hemophilia A: Suboptimal use in a real‐world setting [PDF]
Research and Practice in Thrombosis and Haemostasis, 2022 Background Desmopressin is an important treatment option in nonsevere hemophilia A because it has several benefits compared with factor (F) concentrates, including no inhibitor risk and much lower costs.
Anne‐Fleur Zwagemaker +17 more
doaj +4 more sources
Desmopressin in moderate hemophilia A patients: a treatment worth considering [PDF]
Haematologica, 2018 Desmopressin increases endogenous factor VIII levels in hemophilia A. Large inter-individual variation in the response to desmopressin is observed.
Janneke I. Loomans +12 more
doaj +4 more sources
Desmopressin: an historical introduction [PDF]
Haemophilia, 2007 Summary. This review summarizes the steps that led to the development of desmopressin as a hemostatic agent. This drug has broadened the panel of pharmacological agents that can be used to treat or prevent bleeding in patients with mild hemophilia and von Willebrand disease.
P.M. Mannucci, P. M. MANNUCCI
openaire +4 more sources
Efficacy and comparative analysis of consumer qualities of the Desmopressin intranasal drops in patients with central diabetes insipidus [PDF]
Ожирение и метаболизм, 2014 Objective: To evaluate the effectiveness and conduct a comparative analysis of consumer qualities of desmopressin intranasal drops 0.01% 5ml ("Biopharm", Georgia) in patients with central diabetes insipidus (CDI).
doaj +2 more sources
Preparation and Characterization of Desmopressin Peptide Attached Multi-Walled Carbon Nanotube [PDF]
Trends in Peptide and Protein Sciences, 2019 Desmopressin, a synthetic analogue of vasopressin, has many applications in medicine including diabetes insipidus, night bedwetting, and hemophillia A. In this work, the attachment of desmopressin to multi-walled carbon nanotubes (MWCNTs), functionalized
Mohammadreza Gholibeikian +2 more
doaj +2 more sources
Desmopressin in the treatment of nocturia: clinical evidence and experience
Therapeutic Advances in Urology, 2013 Nocturia is a common and bothersome condition experienced by both men and women. Studies have suggested that nocturia contributes a level of morbidity to those who suffer from the condition, both young and old. Desmopressin has historically been utilized
Fara M. Friedman, Jeffrey P. Weiss
doaj +2 more sources
The effect of F8 missense variants on desmopressin response in people with nonsevere hemophilia A investigated using machine learning [PDF]
Research and Practice in Thrombosis and HaemostasisBackground: Interindividual variability in factor FVIII peak levels after desmopressin administration in people with nonsevere hemophilia A underscores the need for individual testing before clinical application.
Michael E. Cloesmeijer +8 more
doaj +2 more sources
Endocrinology Research and PracticeObjective: The discontinuation of corticotropin-releasing hormone (CRH) production has shifted clinical practice toward the use of desmopressin for dynamic stimulation testing in the diagnosis of Cushing’s disease (CD).
Ekin Yiğit Köroğlu +8 more
doaj +2 more sources
Case Report of Acute Severe Hyponatremia Induced by Desmopressin Administration During Chemotherapy [PDF]
Clinical Case ReportsPatients undergoing chemotherapy are prone to developing hyponatremia due to insufficient oral intake because of nausea and vomiting, administration of large volumes of intravenous fluids, syndrome of inappropriate antidiuretic hormone secretion induced ...
Koutaro Ono +6 more
doaj +2 more sources
Global estimation of the bleeding episodes treatable with desmopressin in von Willebrand disease and hemophilia A [PDF]
HaematologicaDesmopressin increases plasma factor VIII and von Willebrand factor in non-severe hemophilia A (Hem A) and type 1 von Willebrand disease (VWD), following intravenous infusions, subcutaneous injections or nasal spray.
Alessandro Gringeri +4 more
doaj +2 more sources